The healthcare supply chain platform plans to expand its AI capabilities, grow enterprise deployments, and enter new GCC markets.

The Saudi-based startup has raised USD 12 million in a Series A funding round as it looks to scale its AI-powered procurement operating system across healthcare systems in the GCC and beyond.

Why You Should Care

Healthcare supply chains across emerging markets remain fragmented, with hospitals, pharmacies, and suppliers often operating across disconnected systems. Aumet is positioning itself as the infrastructure layer connecting procurement, inventory management, and decision-making into a single platform.

For investors, the raise reflects continued interest in healthcare infrastructure and AI applications that solve operational inefficiencies. It also signals growing momentum behind enterprise healthcare technology in the region.

The Series A round was led by Emkan Capital, with participation from Qatar Development Bank, SABAH Fund, and AAIC. It also saw participation from existing investors Shorooq Partners and Right Side Capital Management. This is alongside healthcare-focused investors Cigalah Group and Salehiya Trading Company.

Founded by Yahya Aqel and Adel Haddad, Aumet is an AI-first procurement operating system for healthcare. It connects pharmacies, hospitals, and suppliers through a unified digital platform. It operates across Saudi Arabia, Jordan, Egypt, and Oman.

“At Aumet, we are building the AI-first operating system that powers procurement decisions across the entire healthcare ecosystem — from individual pharmacies to national healthcare systems. Our ambition is to take what we’ve built in the Middle East and scale it globally,” said Yahya Aqel, CEO and Co-founder of Aumet.

Aumet operates across three product layers. Pulse is a cloud-based system focusing on individual pharmacies. It combines inventory management, marketplace, and AI-powered procurement automation. Meanwhile, Chain is a solution targeting pharmacy chains; it enables centralized procurement and AI-driven decision-making across multi-branch pharmacy operations. Furthermore, Enterprise is its most advanced solution targeting healthcare systems. It is an AI-powered cognitive procurement OS designed for hospitals, ministries of health, and national healthcare systems.

The Ripple

The raise highlights how regional startups are increasingly moving beyond marketplace models toward infrastructure-focused enterprise software.

Traditionally, Healthcare procurement has relied on fragmented legacy systems, particularly across emerging markets. Globally, companies such as Clarium are addressing similar enterprise-level healthcare supply chain challenges in the United States. Furthermore, Aumet aims to tackle these issues across emerging markets, particularly in the Middle East.

The involvement of both financial investors and healthcare industry players in Aumet’s round also reflects how sector-specific enterprise technology is becoming a larger focus area within MENA venture capital.

What to Watch

Looking ahead, with the new capital, it aims to expand its AI capabilities, scale Pulse globally, and grow enterprise deployments. It also aims to enter new markets across the GCC and beyond.

The next phase will likely focus on how quickly the company can scale beyond its existing markets while managing larger healthcare networks and public sector deployments. Its expansion may also offer a clearer signal on how AI-driven procurement systems begin to integrate more deeply into healthcare infrastructure across the region.